Columbus Circle Investors’s Aratana Therapeutics, Inc. PETX Stock Holding History

Columbus Circle Investors’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-144,106	Closed	-$795K	–	309
2016 Q1	$795K	Buy	144,106 +19,667	+16%	+$73.9K	0.01%	247
2015 Q4	$694K	Sell	124,439 -878,224	-88%	-$5.8M	0.01%	262
2015 Q3	$8.48M	Sell	1,002,663 -123,378	-11%	-$2.09M	0.07%	203
2015 Q2	$17M	Sell	1,126,041 -18,518	-2%	-$267K	0.12%	181
2015 Q1	$18.3M	Buy	1,144,559 +607,540	+113%	+$10.8M	0.12%	166
2014 Q4	$9.57M	Buy	+537,019	New	+$6.69M	0.07%	204

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Columbus Circle Investors's PETX Position: Q2 2016 in Review

Columbus Circle Investors sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2016, closing a stake of 144,106 shares — an estimated $795K sold.

Columbus Circle Investors first reported a position in PETX in Q4 2014 and held it in 6 quarters. The position peaked at $18.3M in Q1 2015. 100 funds tracked by Wall St. Rank hold PETX as of Q2 2016.

Columbus Circle Investors reported no remaining Aratana Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
Columbus Circle Investors sold 144,106 Aratana Therapeutics, Inc. shares in Q2 2016, an estimated $795K.
Columbus Circle Investors first reported a position in Aratana Therapeutics, Inc. in Q4 2014 and held it in 6 quarters.
Columbus Circle Investors's Aratana Therapeutics, Inc. position peaked at $18.3M in Q1 2015.
100 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2016.

Based on Columbus Circle Investors's 13F filing for Q2 2016, filed 2 Aug 2016.